CBOE
Price
$375.42Alerts
Change
+$6.53 (+1.77%)
Updated
Nov 13 closing price
Capitalization
36.89B
75 days until earnings call
Intraday BUY SELL Signals
GEHC
Price
$83.02Alerts
Change
+$1.18 (+1.44%)
Updated
Nov 13 closing price
Capitalization
37.21B
Intraday BUY SELL Signals
HBAN
Price
$15.82Alerts
Change
+$0.09 (+0.57%)
Updated
Nov 13 closing price
Capitalization
31.26B
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CBOE or GEHC or HBAN

CBOE vs GEHC vs HBAN Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CBOE with price predictions
Nov 13, 2026

CBOE in upward trend: price rose above 50-day moving average on October 08, 2026

CBOE moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for CBOE crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

The 50-day moving average for CBOE moved above the 200-day moving average on October 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +4.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBOE advanced for three days, in 203 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 172 of 272 cases where CBOE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBOE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

CBOE broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 5 (best 1 - 100 worst), indicating outstanding price growth. CBOE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.558) is normal, around the industry mean (4.143). P/E Ratio (27.449) is within average values for comparable stocks, (19.659). Projected Growth (PEG Ratio) (2.241) is also within normal values, averaging (1.780). Dividend Yield (0.010) settles around the average of (0.017) among similar stocks. P/S Ratio (5.615) is also within normal values, averaging (7.166).

A.I.Advisor
a Summary for GEHC with price predictions
Nov 13, 2026

GEHC sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for GEHC moved above the 200-day moving average on November 11, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on GEHC as a result. In 44 of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

GEHC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GEHC crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +7.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEHC advanced for three days, in 155 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 94 of 169 cases where GEHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Bearish Trend Analysis

The 10-day RSI Indicator for GEHC moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 17 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 46 cases where GEHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

GEHC broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. GEHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.390) is normal, around the industry mean (4.142). P/E Ratio (18.938) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.666) is also within normal values, averaging (11.253). Dividend Yield (0.002) settles around the average of (0.011) among similar stocks. P/S Ratio (1.363) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for HBAN with price predictions
Nov 13, 2026

HBAN in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 20, 2026

HBAN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 48 similar instances where the stock broke above the upper band. In 35 of the 48 cases the stock fell afterwards. This puts the odds of success at 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HBAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 59 cases where HBAN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.

The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on HBAN as a result. In 51 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

HBAN moved above its 50-day moving average on November 13, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HBAN crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.

Following a +3.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where HBAN advanced for three days, in 174 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 149 of 279 cases where HBAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating fairly steady price growth. HBAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.051) is normal, around the industry mean (1.262). P/E Ratio (11.720) is within average values for comparable stocks, (13.480). Projected Growth (PEG Ratio) (1.829) is also within normal values, averaging (1.194). Dividend Yield (0.040) settles around the average of (0.036) among similar stocks. P/S Ratio (2.863) is also within normal values, averaging (3.740).

The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HBAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.

FUNDAMENTALS RATINGS
CBOE vs HBAN: Fundamental Ratings
CBOE
HBAN
OUTLOOK RATING
1..100
4550
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
2069
SMR RATING
1..100
376
PRICE GROWTH RATING
1..100
551
P/E GROWTH RATING
1..100
4836
SEASONALITY SCORE
1..100
4750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HBAN's Valuation (58) in the Regional Banks industry is in the same range as CBOE (90) in the Investment Banks Or Brokers industry. This means that HBAN’s stock grew similarly to CBOE’s over the last 12 months.

CBOE's Profit vs Risk Rating (20) in the Investment Banks Or Brokers industry is somewhat better than the same rating for HBAN (69) in the Regional Banks industry. This means that CBOE’s stock grew somewhat faster than HBAN’s over the last 12 months.

HBAN's SMR Rating (6) in the Regional Banks industry is in the same range as CBOE (37) in the Investment Banks Or Brokers industry. This means that HBAN’s stock grew similarly to CBOE’s over the last 12 months.

CBOE's Price Growth Rating (5) in the Investment Banks Or Brokers industry is somewhat better than the same rating for HBAN (51) in the Regional Banks industry. This means that CBOE’s stock grew somewhat faster than HBAN’s over the last 12 months.

HBAN's P/E Growth Rating (36) in the Regional Banks industry is in the same range as CBOE (48) in the Investment Banks Or Brokers industry. This means that HBAN’s stock grew similarly to CBOE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBOEGEHCHBAN
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
53%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
64%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
64%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
N/A
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 12 days ago
69%
Bullish Trend 26 days ago
61%
Declines
ODDS (%)
Bearish Trend 18 days ago
42%
Bearish Trend 4 days ago
60%
Bearish Trend 10 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
53%
COMPARISON
Comparison
Nov 16, 2026
Stock price -- (CBOE: $375.42, GEHC: $83.02, HBAN: $15.82)
Brand notoriety: CBOE and GEHC are not notable and HBAN is notable
CBOE represents the Financial Publishing/Services industry, GEHC is part of the Medical/Nursing Services industry, and HBAN is in the Regional Banks industry.
Current volume relative to the 65-day Moving Average: CBOE: 78%, GEHC: 59%, HBAN: 33%
Market capitalization -- CBOE: $36.89B, GEHC: $37.21B, HBAN: $31.26B
CBOE [@Financial Publishing/Services] is valued at $36.89B. GEHC’s [@Medical/Nursing Services] market capitalization is $37.21B. HBAN [@Regional Banks] has a market capitalization of $31.26B. The market cap for tickers in the [@Financial Publishing/Services] industry ranges from $1.27M to $137.91B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The market cap for tickers in the [@Regional Banks] industry ranges from $147.87 to $173.74B. The average market capitalization across the [@Financial Publishing/Services] industry is $46.28B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBOE’s FA Score shows that 2 FA rating(s) are green while GEHC’s FA Score has 2 green FA rating(s), and HBAN’s FA Score reflects 1 green FA rating(s).

  • CBOE’s FA Score: 2 green, 3 red.
  • GEHC’s FA Score: 2 green, 3 red.
  • HBAN’s FA Score: 1 green, 4 red.
According to our system of comparison, CBOE is a better buy in the long-term than GEHC, which in turn is a better option than HBAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBOE’s TA Score shows that 5 TA indicator(s) are bullish while GEHC’s TA Score has 6 bullish TA indicator(s), and HBAN’s TA Score reflects 6 bullish TA indicator(s).

  • CBOE’s TA Score: 5 bullish, 4 bearish.
  • GEHC’s TA Score: 6 bullish, 4 bearish.
  • HBAN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, HBAN is a better buy in the short-term than GEHC, which in turn is a better option than CBOE.

Price Growth

CBOE (@Financial Publishing/Services) experienced а +6.27% price change this week, while GEHC (@Medical/Nursing Services) price change was +0.78% , and HBAN (@Regional Banks) price fluctuated +2.26% for the same time period.

The average weekly price growth across all stocks in the @Financial Publishing/Services industry was +0.29%. For the same industry, the average monthly price growth was +8.02%, and the average quarterly price growth was +14.02%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.

The average weekly price growth across all stocks in the @Regional Banks industry was +1.00%. For the same industry, the average monthly price growth was +3.45%, and the average quarterly price growth was +11.77%.

Reported Earning Dates

CBOE is expected to report earnings on Jan 29, 2027.

HBAN is expected to report earnings on Jan 28, 2027.

Industries' Descriptions

@Financial Publishing/Services (+0.29% weekly)

The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Regional Banks (+1.00% weekly)

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

View a ticker or compare two or three
Interact to see
Advertisement

CBOE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBOE has been loosely correlated with CME. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CBOE jumps, then CME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBOE
1D Price
Change %
CBOE100%
+1.77%
CME - CBOE
60%
Loosely correlated
+0.78%
ICE - CBOE
30%
Poorly correlated
+0.37%
MKTX - CBOE
29%
Poorly correlated
+0.04%
TW - CBOE
29%
Poorly correlated
+0.84%
ARBK - CBOE
22%
Poorly correlated
-1.77%
More

GEHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEHC has been loosely correlated with CPAY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GEHC jumps, then CPAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEHC
1D Price
Change %
GEHC100%
+1.44%
CPAY - GEHC
60%
Loosely correlated
+1.36%
PHG - GEHC
57%
Loosely correlated
+0.97%
EEFT - GEHC
57%
Loosely correlated
+1.46%
GEN - GEHC
56%
Loosely correlated
+2.39%
ROP - GEHC
54%
Loosely correlated
+0.44%
More

HBAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBAN has been closely correlated with FITB. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if HBAN jumps, then FITB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBAN
1D Price
Change %
HBAN100%
+0.57%
FITB - HBAN
88%
Closely correlated
+1.11%
RF - HBAN
85%
Closely correlated
+1.23%
KEY - HBAN
85%
Closely correlated
+0.61%
PNC - HBAN
85%
Closely correlated
+0.55%
ZION - HBAN
84%
Closely correlated
+0.59%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PARK21.490.30
+1.42%
Park Dental Partners Inc.
FBK54.630.10
+0.18%
FB Financial Corp
CLH293.81-0.03
-0.01%
Clean Harbors
OVID2.54-0.01
-0.39%
Ovid Therapeutics
JWEL1.73-0.05
-2.81%
Jowell Global Ltd